NOVEL POLYMORPHIC CRYSTAL FORMS OF 5-(2-{[6-(2,2-DIFLUORO-2-PHENYLETHOXY)HEXYL]AMINO}-1-(R)-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE, HEMINAPADISYLATE AS AGONIST OF THE &bgr；2 ADRENERGIC RECEPTOR.

• 收藏
• 分享

专利权人:

ALMIRALL; S.A.

发明人:

AMAT MESTRES, GEMMA,BALAGUER ARDANUY, ELVIRA,CARRERA CARRERA, FRANCESC,MARCUETA HEREU, IOLANDA,MOYES VALLS, ENRIQUE

申请号：

SG11201405590X

公开号：

SG11201405590XA

申请日:

2013.03.15

申请国别(地区):

SG

年份:

2014

代理人:

摘要：

The present invention is directed to novel polymorphic crystal forms of a 5-{2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one, heminapadisylate. The invention is also directed to pharmaceutical compositions comprising said polymorphic crystal forms, methods of using them to treat respiratory diseases associated with ²2 adrenergic receptor activity and a process for preparing such polymophic crystal forms.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/